ArticleScientific reports2025
Hypoxia preconditioned plasma increases the expression of growth factors to accelerate diabetic wound healing by promoting angiogenesis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hypoxia preconditioned plasma (HPP) is generated by cultivating blood under hypoxic conditions, allowing blood cells to naturally regulate the production of growth factors in response to hypoxia, which seems ideal for diabetic wound treatment. This study aims to verify the efficacy and underlying mechanism of HPP on diabetic wound healing. The concentrations of angiogenesis-related factors (VEGF, PDGF, EGF, IGF, TSP1, PF4) measured by ELISA were significantly increased in HPP. In vitro, HPP promoted the proliferation and migration of HUVECs and HSF, and enhanced the tube formation of HUVECs. In vivo, HPP promotes wound angiogenesis and collagen deposition, significantly accelerating diabetic wound healing (84 ± 10% vs. 65 ± 20%, p < 0.01). Furthermore, western blot and qPCR results showed that both in cells and wounds, the expression of pro-angiogenic factors, as well as p-AKT, was increased in HPP. These findings suggest that HPP benefits diabetic wound healing and may represent a promising therapeutic approach for diabetic wound healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.